After another 6-12 months of waiting with dead money, it will likely be the outcome that PMCB will have to go back to start. Their human safety study was only done with 14 patients. No way the FDA accepts that as an acceptable representation of the human population, especially with a different WCB and MCB. They already know this, as was posted from an insider in the know on their official Facebook feed.
Market Data 
Markets 
AI
